Tackling Surgical Morbidity and Mortality through Modifiable Risk Factors in Cancer Patients
Open Access
Abstract
Despite advances in surgical techniques, surgical morbidity and mortality remain important public health problems. Postoperative complications often lead to greater morbidity and mortality, as well as increased length of hospital stay and medical costs. Therefore, a reduction in postoperative complications is particularly important with regard to positive long-term outcomes in patients with cancer. To improve patients’ postoperative prognosis, it is necessary to screen for and focus on modifiable risk factors and their subsequent resolution. Recently, it was reported that nutritional status, inflammation and surgical approaches are related to postoperative morbidity and mortality. Therefore, in this review article, we describe the current evidence regarding modifiable risk factors influencing surgical morbidity and mortality as well as future directions for improved postoperative management in cancer patients.Keywords
This publication has 89 references indexed in Scilit:
- Does delay of adjuvant chemotherapy impact survival in patients with resected stage II and III colon adenocarcinoma?Cancer, 2010
- Preoperative systemic inflammation predicts postoperative infectious complications in patients undergoing curative resection for colorectal cancerBritish Journal of Cancer, 2009
- Chronic inflammation that facilitates tumor progression creates local immune suppression by inducing indoleamine 2,3 dioxygenaseProceedings of the National Academy of Sciences, 2008
- Cancer-related inflammationNature, 2008
- National Surgical Quality Improvement Program (NSQIP) Risk Factors Can Be Used to Validate American Society of Anesthesiologists Physical Status Classification (ASA PS) LevelsAnnals of Surgery, 2006
- ESPEN Guidelines for Nutrition Screening 2002Clinical Nutrition, 2003
- Postoperative cell mediated immune response is better preserved after laparoscopic vs open colorectal resection in humansSurgical Endoscopy, 2003
- Inflammation and cancerNature, 2002
- Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid ArthritisJAMA, 2000
- Acute-Phase Proteins and Other Systemic Responses to InflammationNew England Journal of Medicine, 1999